Optimal management of low-risk gestational trophoblastic neoplasia.

about

Solitary lung metastasis from gestational choriocarcinoma resected six years after hydatidiform mole: A case report.Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.

P2860

Q41470457-8E7E25D0-ABE3-4AE1-A03A-9721A21C82C0 Q52690584-99D4F022-2DEC-481A-8916-768446B09FD0

P2860

Optimal management of low-risk gestational trophoblastic neoplasia.

Item

http://www.wikidata.org/entity/Q38620407

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Optimal management of low-risk gestational trophoblastic neoplasia.

@en

type

Item

label

Optimal management of low-risk gestational trophoblastic neoplasia.

@en

prefLabel

Optimal management of low-risk gestational trophoblastic neoplasia.

@en

P1476

Optimal management of low-risk gestational trophoblastic neoplasia.

@en

P2093

Donald P Goldstein

http://www.w3.org/2001/XMLSchema#string

Neil S Horowitz

http://www.w3.org/2001/XMLSchema#string

Ross S Berkowitz

http://www.w3.org/2001/XMLSchema#string

P2860

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects

Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease.

The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(-1).

Epidemiology and aetiology of gestational trophoblastic diseases.

Treatment of gestational trophoblastic tumors.

Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.

Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.

Clinical practice. Molar pregnancy.

Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study.

P304

1293-1304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.2015.1088786

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26517533

http://www.w3.org/2001/XMLSchema#string

Optimal management of low-risk gestational trophoblastic neoplasia.

about

P2860

P2860

Optimal management of low-risk gestational trophoblastic neoplasia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698